Why North America Leads the T-cell Therapy Market and Asia Pacific Is Closing In T-cell therapy is moving out of the lab and into mainstream oncology. Grand View Research puts the global T-cell therapy market at USD 7.1 billion in 2025, rising to USD 9.7 billion in 2026. It projects growth to USD 80.2 billion by 2033, a CAGR of 35.3% from 2026 to 2033.
This post covers where the money is, who is competing for it, where the science is heading, and what could slow things...
0 hisse senetleri
21 Views